UHS

Business Context and Reporting Period

Company: Universal Health Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2002
Business Overview: The Company operates acute care hospitals and behavioral health facilities in the U.S., Puerto Rico, and France. Operations are segmented into Acute Care Services, Behavioral Health Services, and Other (including centralized services and international operations).

Key Financial Metrics

Note: Total Debt calculated as Current maturities of long-term debt ($3,495) + Long-term debt ($658,065) as of Sept 30, 2002.

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 13% ($92 million) for the quarter and 15% ($307 million) for the nine-month period compared to 2001. Growth was driven by an 8% increase in same-facility revenues and $33 million (quarter) / $133 million (nine months) from acquisitions.
• Profitability: Operating income rose 16% for both the quarter and nine-month periods. Net income increased 37% for the quarter and 33% for the nine-month period.
• Expense Drivers:
  • Bad Debt: Provision for doubtful accounts decreased as a percentage of revenue (7.7% vs. 9.5% in Q3; 7.2% vs. 8.8% in YTD), improving margins.
  • Insurance Costs: Professional and general liability insurance expenses increased significantly due to unfavorable market trends and the liquidation of insurer PHICO. Total insurance expense is estimated to be $25 million higher annually in 2002.
  • Labor Costs: Salaries, wages, and benefits increased due to rising rates, particularly for skilled nursing.
• Accounting Changes: Adoption of SFAS No. 142 (Goodwill) in Jan 2002 ceased goodwill amortization, which previously reduced net income by approximately $24 million annually.

Outlook, Risks, and Contingencies

• Capital Expenditures: The Company spent $157 million in the first nine months of 2002. Full-year 2002 capital expenditures are estimated at $200 million to $220 million, funding projects including a new hospital in Las Vegas and expansions in Washington and Texas.
• Liquidity: As of Sept 30, 2002, the Company had $351 million of unused capacity under a $400 million revolving credit facility and $25 million under a commercial paper program.
• PHICO Contingency: Following the liquidation of insurer PHICO, the Company recorded a $40 million pre-tax charge in Q4 2001. Management expects net cash payments for these claims to occur over the next 5-7 years. There is no assurance the ultimate liability will not exceed the reserve.
• Regulatory Risks:
  • Medicare/Medicaid: Reimbursement rates are subject to legislative changes (e.g., Balanced Budget Act). Outlier payment thresholds increased in 2003, expected to reduce payments.
  • HIPAA: Compliance with electronic data interchange and privacy standards is required, with implementation costs expected to be immaterial.
• Compensation Restructuring: The Company terminated a loan program for stock option taxes and replaced it with restricted stock awards, resulting in a net compensation expense adjustment of $2.8 million for the nine months ended Sept 30, 2002.

Investor Verification Checklist

• Insurance Liability: Verify the status of the PHICO liquidation reserve and potential exposure beyond the $40 million charge.
• Reimbursement Trends: Monitor legislative updates regarding Medicare outlier payments and Medicaid funding in key states (Texas, Pennsylvania, Massachusetts).
• Capital Deployment: Track progress and cost overruns on major construction projects (Las Vegas, Washington, Texas, Florida).
• Debt Covenants: Review leverage ratios against the $400 million credit facility terms to ensure continued access to liquidity.
• Goodwill Impairment: Assess the annual goodwill impairment test results, particularly given the cessation of amortization under SFAS 142.